Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone

Journal of Medicinal Chemistry

Volumn 39, Issue 26, 1996, Pages 5053-5063

  Tanis, Steven P ^a   Parker, Timothy T ^a   Colca, Jerry R ^a   Fisher, Roberta M ^a   Kletzein, Rolf F ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 [4 [2 (5 ETHYL 2 PYRIDYL) 1 OXOETHOXY]BENZYL] 2,4 THIAZOLIDINEDIONE; ANTIDIABETIC AGENT; DRUG METABOLITE; PIOGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HYPERGLYCEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN;

ANIMALS; DOGS; HALF-LIFE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MICE; RATS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0030459837     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9605694     Document Type: Article

References (38)

1. DeFronzo, R. A. The Triumvirate: the B-cell, Muscle, Liver. A Collusion Responsible for NIDDM. Diabetes 1988, 37, 667-687.
2. Reaven, G. M. Role of Insulin Resistance in the Pathophysiology of Non-Insulin-Dependent Diabetes Mellitus. Diabetes/Metab. Rev. 1993, 9, 5S-12S.
3. Rubin, R. J.; Altaian, W. M.; Mendelson, D. N. Health Care Expenditures for People with Diabetes Mellitus. J. Clin. Endocrinol. Metab. 1994, 78, 809A-809F.
4. Reaven, G. M. Insulin Secretion and Insulin Action in Non-Insulin-Dependent Diabetes Mellitus: Which Defect is Primary? Diabetes Care 1984, 7, 17-24.
5. Warram, J. H.; Martin, B. C.; Krolewski, A, S.; Soeldner, J. S.; Kahn, C. R. Slow glucose removal rate and hyperinsulinemia precede the development of Type II diabetes in the offspring of diabetic patients. Ann. Int. Med. 1990, 113, 909-915.
6. Colca, J. R. Potential antidiabetic drugs affecting the sensitivity of tissues to insulin. Exp. Opin. Invest. Drugs 1990, 3, 857-860.
7. See: Turner, N. C. New Therapeutic Agents for the Treatment of Insulin Resistance and NIDDM. Drug Discovery Today 1996, 1, 109-116 and references cited therein.
8. Hofmann, C. A.; Colca, J. R. New Oral Thiazolidinedione Antidiabetic Agents Act as Insulin Sensitizers. Diabetes Care 1992, 15, 1075-1078.
9. Weinstein, S. P.; Holand, A.; O'Boyle, E.; Haber, R. S. Effects of Thiazoldidinediones on Glucocorticoid-Induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism 1993, 42, 1365-1369.
10. Iwanishi, M.; Kobayashi, M. Effect of Pioglitazone on Insulin Receptors of Skeletal Muscles from High-Fat-Fed Rats. Metabolism 1993, 42, 1017-1021.
11. Sugiyama, Y.; Taketomi, S.; Shimura, Y.; Ikeda, H.; Fujita, T. Effects of Pioglitazone on Glucose and Lipid Metabolism in Wistar Fatty Rats. Arzneim.-Forsch./Drug Res. 1990, 40, 263-267.
12. Townes, R.; Kostyo, J.; Colca, J. Pioglitazone Inhibits the Diabetogenic Action of Growth Hormone, but Not Its Ability to Promote Growth. Endocrinology 1994, 134, 608-613.
13. Bleasdale, J. E.; Swanson, M. L. Hepatic Insulin Resistance in KKAy mice and its Amelioration by Pioglitazone do not Involve Alterations in Phospholipase C Activity. Biochim. Biophys. Acta 1993, 1181, 240-248.
14. Sizer, K. M.; Smith, C. L.; Jacob, C. S.; Swanson, M. L.; Bleasdale, J. E. Pioglitazone Promotes Insulin-Induced Activation of Phophoinositide 3-Kinase in 3T3-L1 Adipocytes by Inhibiting a Negative Control Mechanism. Mol. Cell. Endocrinol. 1994, 102, 119-129.
15. Kletzien, R. F.; Clarke, S. D.; Ulrich, R. G. Enhancement of Adipocyte Differentiation by an Insulin-Sensitizing Agent. Mol. Pharmacol. 1991, 41, 393-398.
16. Steiner, K. E.; Lien, E. L. Hypoglycemic agents which do not release insulin. Prog. Med. Chem. 1987, 24, 209.
17. Colca, J. R.; Morton, D. R. Antihyperglycemic thiazolidinediones: ciglitazone and its analogs. In New Antidiabetic Drugs; Bailey, C. J., Flatt, P. R., Eds.; Smith-Gordon: London, 1990; p 255.
18. Sohda, T.; Momose, Y.; Meguro, K.; Kawamatsu, Y.; Sugiyama, Y.; Ikeda, H. Studies on Antidiabetic Agents. Synthesis and Hypoglycemic Activity of 5-[4-(Pyridylalkoxy)-benzyl]-2,4-thiazolidinediones. Arzneim-Forsch./Drug Res. 1990, 40, 37-42.
19. Yoshioka, T.; Fujita, T.; Kanai, T.; Aizawa, Y.; Kurumada, T.; Hasegawa, K.; Horikoshi, H. Studies on Hindered Phenols and Analogs. 1. Hypolipidemic and Hypoglycemic Agents with Ability To Inhibit Lipid Peroxidation. J. Med. Chem. 1989, 32, 421-428.
20. Clark, D. A.; Goldstein, S. W.; Volkmann, R. A.; Eggler, J. F.; Holland, G. F.; Hulin, B.; Stevenson, R. W.; Kreutter, D. K.; Gibbs, E. M.; Krupp, M. N.; Merrigan, P.; Kelbaugh, P. L.; Andrews, E. G.; Tickner, D. L.; Suleske, R. T.; Lamphere, C. H.; Rajeckas, F. J.; Kappeler, W. H.; McDermott, R. E.; Hutson, N. J.; Johnson, M. R. Substituted Dihydrobenzopyran and Dihydrobenzofuran Thiazolidine-2,4-diones as Hypoglycemic Agents. J. Med. Chem. 1991, 34, 319.
21. Hulin, B.; Clark, D. A.; Goldstein, S. W.; McDermott, R. E.; Dambek, P. J.; Rappeler, W. H.; Lamphere, C. H.; Lewis, D. M.; Rizzi, J. P. Novel Thiazolidine-2,4-diones as Potent Euglycemic Agents. J. Med. Chem. 1992, 35, 1853-1864.
22. Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. L. [[ω-(Heterocyclamino)alkoxy]benzyl]-2,4-thiazolidinediones as Potent Antihyperglycemic Agents. J. Med. Chem. 1994, 37, 3977-3985.
23. Zhong, W. Z.; Lakings, D. B. Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatography with ultraviolet (229 nm) detection. J. Chromatogr. 1989, 490, 377-385.
24. Loux, S, J.; Schuette, M. R.; Jone, B. W.; Rousch, K. E.; Greenfield, J. C. Disposition in rat of pioglitazone, a thiazolidinedione antidiabetic. Abstr. Papers Am. Chem. Soc. 1992, 204, P163-Medi.
25. Krieter, P. A.; Colletti, A. E.; Doss, G. A.; Miller, R. R. Disposition and Metabolism of the Hypoglycemic Agent Pioglitzaone in Rats. Drug Metab. Dispos. 1994, 22, 625-630.
26. Sohda, T.; Ikeda, H.; Meguro, K. Studies on Antidiabetic Agents. XII. Synthesis and Activity of the Metabolites of (+/-)-5[p[2[-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione (Pioglitazone). Chem. Pharm. Bull. 1995, 43, 2168-2172.
27. Frank, R. L.; Biegen, J. R.; Dearborn, R. J.; Myers, R. L.; Woodward, F. E. Pyridines. I. Aldehyde-collidine and 5-Ethyl-2-vinylpyridines. J. Am. Chem. Soc. 1946, 68, 1368-1369.
28. Mitsunobu, O. The Use of Diethyl Azodicarboxylate and Triethylphosphine in Synthesis and Transformation of Natural Products. Synthesis 1981, 1-28.
29. J. Huber, Pharmacia and Upjohn, Inc., Chemical Process Research and Development, Kalamazoo, MI, unpublished results; we thank Joel for sharing his work with us.
30. 4 and Catalytic Amounts of Chiral Cobalt Semicorrin Complexes. Angew. Chem., Int. Ed. Engl. 1989, 28, 60-61.
31. Carlson, L. A.; Hedbom, C.; Helgstrand, E.; Misiorny, A.; Sjöberg, B.; Stejernström, N. E.; Westin, G. Potential hypplipidemic agents. IV. Syntheses of some halo-substituted pyridine compounds. Effects on noradrenaline-stimulated free fatty acid mobilization. Acta Pharm. Seuc. 1972, 9, 411-418.
32. Boekelheide, V.; Linn, W. J. Rearrangements of N-Oxides. A Novel Synthesis of Pyridyl Carbinols and Aldehydes. J. Am. Chem. Soc. 1954, 76, 1286-1291.
33. 5/DMSO/ Triethylamine (PDT): A Convenient Procedure for Oxidation of Alcohols to Ketones and Aldehydes. J. Org. Chem. 1987, 52, 5621-5622.
34. Hofmann, C.; Lorenz, K.; Colca, J. R. Glucose Transport deficiency in Diabetic Animals Is Corrected by Treatment with the Oral Antihyperglycemic Agent Pioglitazone. Endocrinology 1991, 129, 1915-1925.
35. Iwatsuka, H.; Shino, A.; Suzuoki, Z. General Survey of Diabetic Features of Yellow KK Mice. Endocrinol. Jpn. 1970, 17, 23-25.
36. A registered trademark of Alpkem, Clackamas, OR.
37. Sohda, T.; Meguro, K.; Kawamatsu, Y. Studies on Antidiabetic Agents. IV. Synthesis and Activity of the Metabolites of 5-[4-(1-Methylcyclohexylmethoxybenzyl]-2,4-thiazolidinedione(Ciglitazone). Chem. Pharm. Bull. 1984, 32, 2267-2278.
38. Still, W. C,; Kahn, M.; Mitra, A. Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution. J. Org. Chem. 1978, 43, 2923-2925.